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Abstract: Lung emphysema represents a major public health burden and still accounts for five percent
of all deaths worldwide. Hence, it is essential to further understand this disease in order to develop
effective diagnostic and therapeutic strategies. Lung emphysema is an irreversible enlargement of the
airways distal to the terminal bronchi (i.e., the alveoli) due to the destruction of the alveolar walls.
The two most important causes of emphysema are (I) smoking and (II) ฀1-antitrypsin-deficiency. In
the former lung emphysema is predominant in the upper lung parts, the latter is characterized by a
predominance in the basal areas of the lungs. Since quantification and evaluation of the distribution
of lung emphysema is crucial in treatment planning, imaging plays a central role. Imaging modalities
in lung emphysema are manifold: computed tomography (CT) imaging is nowadays the gold standard.
However, emerging imaging techniques like dynamic or functional magnetic resonance imaging (MRI),
scintigraphy and lately also the implementation of radiomics and artificial intelligence are more and more
diffused in the evaluation, diagnosis and quantification of lung emphysema. The aim of this review is
to shortly present the different subtypes of lung emphysema, to give an overview on prediction and risk
assessment in emphysematous disease and to discuss not only the traditional, but also the new imaging
techniques for diagnosis, quantification and evaluation of lung emphysema.
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Abstract: Lung emphysema represents a major public health burden and still accounts for five percent of 
all deaths worldwide. Hence, it is essential to further understand this disease in order to develop effective 
diagnostic and therapeutic strategies. Lung emphysema is an irreversible enlargement of the airways distal to 
the terminal bronchi (i.e., the alveoli) due to the destruction of the alveolar walls. The two most important 
causes of emphysema are (I) smoking and (II) α1-antitrypsin-deficiency. In the former lung emphysema is 
predominant in the upper lung parts, the latter is characterized by a predominance in the basal areas of the 
lungs. Since quantification and evaluation of the distribution of lung emphysema is crucial in treatment 
planning, imaging plays a central role. Imaging modalities in lung emphysema are manifold: computed 
tomography (CT) imaging is nowadays the gold standard. However, emerging imaging techniques like 
dynamic or functional magnetic resonance imaging (MRI), scintigraphy and lately also the implementation 
of radiomics and artificial intelligence are more and more diffused in the evaluation, diagnosis and 
quantification of lung emphysema. The aim of this review is to shortly present the different subtypes of lung 
emphysema, to give an overview on prediction and risk assessment in emphysematous disease and to discuss 
not only the traditional, but also the new imaging techniques for diagnosis, quantification and evaluation of 
lung emphysema. 
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Introduction
Lung emphysema represents a major public health burden 
and still accounts for five percent of all deaths worldwide (1). 
Hence, it is essential to further understand this disease 
in order to develop effective diagnostic and therapeutic 
strategies.
Lung emphysema is an irreversible destruction of 
alveolar walls resulting in enlargement of the distal airspaces 
(2,3). Although emphysema initially does not involve 
fibrosis, end-stage emphysema may lead to a reparative 
response that ultimately leads to pulmonary fibrosis. There 
are three different types of pulmonary emphysema: (I) 
panlobular, (II) centrilobular, and (III) septal emphysema 
(3,4). Additionally, severity and distribution of lung 
emphysema can give hints to causes of emphysema: While 
for example smoking related emphysema is typically 
predominant in the upper lung areas, lung emphysema 
due to α1-antitrypsin-deficiency is located in the basal 
lung areas. Lung emphysema distribution can also provide 
important information for the pre-operative evaluation of 
patients: heterogeneous emphysema is known to be more 
responsive to lung volume reduction (LVR) as for example 
homogeneously distributed emphysema (5). 
This knowledge makes imaging a central player in the 
evaluation of lung emphysema: The main goal of imaging 
is to assess the extent and distribution of emphysema and to 
detect concomitant findings such as infections or identify 
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malignancies (6).
The imaging modalities, which can be used for the 
evaluation of emphysema, are manifold: Due to its high 
spatial resolution, computed tomography (CT) remains 
the gold standard in the evaluation of lung parenchyma—
but other imaging modalities, such as magnetic resonance 
imaging (MRI) or scintigraphy, have increased its 
importance in the last years.
The aim of this review article is to present the different 
subtypes of lung emphysema, to give an overview on 
prediction and risk assessment in emphysematous disease 
and to discuss not only the traditional, but also the new 
imaging techniques for diagnosis, quantification and 
evaluation of lung emphysema. 
Types of emphysema
Elastase is produced by alveolar macrophages and 
neutrophils, both of which are increased in smokers. 
Elastase is a powerful destructive enzyme, which functions 
in the host defence mechanism, but an excess can be 
harmful to the tissues. α1-antitrypsin normally neutralizes 
elastase. Either a surplus of elastase (in smoking-related 
emphysema) or a deficiency of α1-antitrypsin (in α1-
antitrypsin-deficiency) can result in lung destruction and 
finally in emphysema (2,3).
Lung emphysema can be divided into three major 
subtypes at autopsy: (I) centrilobular, (II) paraseptal, and (III) 
panlobular emphysema. These subtypes can also be defined 
visually on CT (Figure 1).
Centrilobular emphysema (CLE)
CLE is generally described as an abnormal magnification 
of airspaces centered on the respiratory bronchiole with 
fusion of destroyed lobules in grievous cases (3,7,8). CLE is 
a smoking-related disease of the lungs and predominantly 
affects the upper lobes. As in all smoking-related lung 
diseases (such us respiratory bronchiolitis, desquamative 
interstitial pneumonia, Langerhans Cell Histiocytosis of the 
lung) also in lung emphysema the center of the secondary 
pulmonary lobule is primarily affected. Moreover, single 
subtypes of emphysema may have different pathophysiology. 
For instance, Smith et al. (9) could show that tobacco users 
with mainly CLE had a more important level of cigarette 
exposure, higher lung volumes, and lower lung diffusion 
Figure 1 Different types of emphysema in axial (upper row) and coronal (lower row) reconstructions. (A,D) mild form of centrilobular 
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Figure 2 Conventional chest radiography of a 38-year-old female patient with α1-antitrypsin deficiency showing typical signs of emphysema: 
(I) the barrel shaped thoracic cage with flattening of the hemi-diaphragmatic domes, (II) hyperlucency of the lung tissue due to overinflation 
and rarefication of vessels, (III) enlargement of the retrosternal clear space >2.5 cm; and (V) narrow configuration of the cardiac silhouette.
BA
capacity than those lacking emphysematous changes 
of the lung. Contrarily, smokers with a predominantly 
“panlobular” pattern of emphysema had a comparably lower 
body mass index than smokers without emphysematous 
changes (10).
Paraseptal emphysema
Paraseptal emphysema allude to emphysematous lung 
changes adjacent to the pleura (3,7,8). It is usually seen in 
combination with other forms of emphysema (10) and also 
smoking related. Especially in patients who smoke marijuana 
severe cases of paraseptal emphysema are seen (11). 
Due to its subpleural location, paraseptal emphysema is a 
risk factor for pneumothorax (10).
Panacinar emphysema
Panacinar emphysema (or also referred to as panlobular 
emphysema) is often characterized as abnormal dilation 
distributed throughout the pulmonary lobule. It affects 
the entire acinus diffusely throughout the lung. α1-
antitrypsin-deficiency is cause of panlobular emphysema. 
The emphysematous changes are usually more sever at the 
lung bases (12). Another cause of panacinar emphysema is 
primary ciliary dysfunction.
Additionally to the different subtypes of emphysema, 
severity and distribution can be evaluated on CT and can 
give important hints to the causes of emphysema: While 
for example smoking related emphysema is typically 
predominant in the upper lung areas, lung emphysema due 
to α1-antitrypsin-deficiency is located in the basal lung 
areas (3,7,8).
Traditional imaging in emphysema
Conventional radiography 
Conventional chest radiography (chest X-ray) has been the 
backbone of imaging for more than 100 years (13). Although 
chest X-ray is one of the oldest and least sophisticated 
imaging examinations, it remains one of the most commonly 
used methods due to its wide availability, low cost, and fast 
implementation (14-17). The two most important signs of 
lung emphysema on X-ray are (I) the barrel shaped thoracic 
cage with flattening of the hemi-diaphragmatic domes, and 
(II) hyperlucency of the lung tissue due to overinflation and 
rarefication of vessels (Figure 2). Auxiliary findings comprise 
enlargement of the intercostal areas, enlargement of the 
retrosternal clear space >2.5 cm, narrow configuration of 
the cardiac silhouette, increased markings pattern, and the 
presence of bullae (4).
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Since, conventional radiography is a projection-based 
imaging technique, it is often impossible to distinguishing 
structures of equal density next to each other or overlapping 
different structures (18). Chest X-ray has only a sensitivity 
of 40% in identifying emphysema (4), little specificity and 
high interobserver disagreement. These facts hinder a solid 
and reproducible quantification of emphysema burden in 
COPD patients (19).
The main role of X-ray in emphysema is to investigate 
for concomitant findings that should be evaluated before 
therapy planning (infection, pleural scarring and pulmonary 
masses) and plays an essential role in follow-up imaging. 
Chest X-ray is broadly used for postinterventional 
evaluation following placement of endobronchial 
valve, sealant or coil implantation or after LVR and its 
potential complications such as device displacement or 
pneumothorax. 
For a better representation of the extent and distribution 
of emphysematous lung changes, as well as for a sensitive 
recognition of absolute contraindication for LVR procedure, 
further evaluation with chest CT is advised.
CT 
Due to its high spatial resolution, the opportunity of 
three-dimensional reformation and quantification CT is 
the preferred imaging modality in the evaluation of lung 
emphysema. CT allows for an easy quantification and 
characterization of emphysematous destructed lung (19,20). 
CT is also the imaging modality of choice when it is up to 
assess heterogeneity and distribution of emphysematous 
lung changes when it is up to find suitable candidates for 
LVR or endobronchial valve placement: The National 
Emphysema Treatment Trial (NETT) for example, revealed 
that subjects with upper lobe predominant or heterogeneous 
emphysematous changes are benefitting the most from 
LVR (5), while patients with a homogeneous distribution 
had a lesser beneficial effect after treatment. 
CT is also used to identify concomitant conditions such 
as malignancy and airway involvement (i.e., bronchiectasis, 
tracheomalacia, lung compression, mucus plugging and 
thickening of the bronchial walls) (19). Moreover, with 
CT it is possible to detect the presence of air trapping and 
bronchial wall collapse, when additional expiratory CT 
series are acquired (4). 
Quantification of emphysema
Quantification can be done by (I) visual scoring, (II) 
semiquantitative methods using densitometry or by (III) 
quantification.
The most widespread utilized visual score is the Goddard 
score, through which the observer evaluates the degree of 
severity of emphysematous lung changes at three distinct 
zones in either individual lung. For each of these six zones, 
a numerical score of 0 to 4 is given (0 is defined as no 
presence of emphysema to 4 which is defined as more than 
76% of emphysema). The Goddard score can range from 
0 to 24. Furthermore, the emphysema distribution (i.e., 
heterogeneity) is also assessed at each location. Different 
studies showed a high agreement between readers, when 
scoring is performed by experienced radiologists or 
pulmonologists (21,22). Contrary to this, other authors still 
report high interobserver variability of this technique: In 
the NETT, despite the use of experienced and previously 
trained chest radiologists, significant inter- and intra-reader 
variability in the quantification of lung emphysema was 
reported (5). 
Due to the fact that visual scoring is neither sensitive nor 
precise, to date primarily semiquantitative and quantitative 
approaches are used for the evaluation of the extend of lung 
emphysema.
Semiquantitative evaluation uses simple methods 
which do not require the use of sophisticated software: for 
instance, by (I) sagittal reformations, and (II) colour coding 
the severity and distribution of emphysema using the CT 
densitometry can be performed. Further, CT densitometry 
images enable for a precise, less observer-dependent 
evaluation of emphysematous lung changes compared 
to axial and multiplanar CT images and have therefore 
potential to be used in LVR surgery planning (23).
To date, quantitative methods are the gold standard in 
the assessment of and manifold commercially available 
software tools allow for an automated quantification of 
lung emphysema. The first step is to virtually remove 
other anatomic structures such as the chest wall and the 
mediastinum from the lung parenchyma. In a second 
step, the remaining lung parenchyma is evaluated voxel 
by voxel for different CT attenuations, the so-called 
Hounsfield Units (HU). HU are used to measure the 
density of each voxel and according to generally accepted 
thresholds [Gevenois et al. (24,25) recommended a cut-off 
value for lung emphysema on CT scans is –950 HU] it is 
possible to distinguish normal lung tissue from emphysema 
(19,26). Finally, the burden of emphysema is defined as 
the relative amount of lung parenchyma inferior to the 
chosen threshold. Both, the observer and the software based 
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method, can be used additionally for the classification of the 
anatomic distribution of emphysematous lung changes (6). 
Newer and more sophisticated techniques allow for a 
depiction of emphysema clusters, providing more profound 
information on heterogeneity (27). Despite the above 
mentioned semi-quantitative and quantitative approaches, 
the validation of the source images remains crucial in 
order to don’t overlook concomitant findings such as 
malignancies, infections or evaluation of fissures. 
Fissure evaluation
When patients are evaluated for endovascular valves 
placement as possible treatment options, lung fissure 
evaluation plays besides the quantification and distribution 
of emphysema a crucial role (28). Sciurba et al. evaluated 
patients were HRCT was used to evaluate distribution 
of emphysema and fissure anatomy to find suitable lung 
regions for endobronchial valve placements and could show 
that these patients had a better post-interventional outcome 
than the control-group (29). This is due to the fact, that 
incomplete fissures contribute to collateral ventilation and 
hamper the results of endobronchial valve treatment. 
In a large European study on endobronchial valves lung 
volume reduction (EBV) complete interlobar fissures were 
found only in one-third of patients (30).
Nowadays, there are to options for the assessment of 
fissure integrity: (I) invasively with the Chartis Pulmonary 
assessment System (CPAS) (31) or (II) non-invasively 
by using CT. Quantitative CT has been shown to be 
comparable to CPAS and is therefore a useful, non-invasive 
method to select suitable candidates for EBV (32). When 
fissure integrity quantified by CT is below 95%, additional 
bronchoscopic assessment with CPAS is necessary to 
exclude alternative ventilation.
One drawback in  CT based evaluat ion i s  that 
fissure validation can be difficult in cases with severe 
emphysema, showing low interobserver agreement (33). 
In these cases multiplanar reformations in coronal and 
sagittal planes appeared to be useful in the assessment of 
fissure integrity (34).
Minimum intensity projection (MinIP)
An easy and straightforward method for a better 
visualization of pulmonary emphysema is the MinIP: 
MinIP images highlight areas with reduced CT attenuation 
in the lung parenchyma. This allows prompt detection 
of emphysematous areas of the lung (35). Ghonge et al. 
suggests window widths of 350–500 HU and a window level 
of −750 to −900 HU for image interpretation.
Scintigraphy
A different imaging modality, which can be used in the 
evaluation of severe lung emphysema is scintigraphy 
(Figure 3). With scintigraphy it is possible to visualize 
ventilation and perfusion of the lungs.  With this 
method upper-lobe predominance and heterogeneity 
of emphysematous lung changes can be visualized and 
combined with functional data such as perfusion. The 
technique is especially helpful in the evaluation for the 
detection of severely emphysema affected areas in the lung 
in heterogeneous emphysema, but struggles in subjects 
with a homogeneous distribution of emphysema (36). In 
scintigraphy the lung is divided in three distinct zones 
(i.e., upper, middle and lower zonr). Information on tracer 
uptake, corresponding to ventilation and perfusion, are 
provided for these three distinct lung zones.
Some authors, despite the high agreement between lung 
perfusion evaluated on HRCT and on scintigraphy, criticize 
scintigraphy for the lack of additional information to 
HRCT making scintigraphy superfluous in the assessment 
of lung emphysema (37,38). 
New techniques:
Dual energy CT
Conventional dual energy CT
Another technique for quantification of emphysema 
is based on dual-energy CT (DECT) (Figure 4). With 
this technique pulmonary perfusion is assessed by the 
measurement of iodine dispersion maps or lung ventilation 
by measurement of the distribution of injected iodine 
contrast media (39). The principle the technique is the 
acquisition of images at different X-ray energies in order to 
analyse the resultant images for differences in attenuation. 
With this approach iodine maps of the lung parenchyma 
reflecting the perfusion can be generated. These maps can 
provide additional physiological information in patients 
with lung emphysema as mere morphological assessment 
with standard CT can (40). Pansini et al. (41) evaluated 
pulmonary perfusion on a lobar level in tobacco users with 
dual-energy CT to investigate for connections between 
the degree of parenchymal destruction and alteration of 
pulmonary perfusion. They found that regional alterations 
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Figure 3 Lung scintigraphy in a 43-year-old female patient with COPD GOLD IV showing perfusion maps in (A) anteroposterior, (B) right 
oblique and (C) left oblique perfusion maps. Emphysematous lung areas in CT lung windows (D,E,F) correspond to areas on scintigraphy 







of pulmonary perfusion can be visualized by dual-energy 
CT in smokers with predominant emphysematous lung 
changes.
Lung perfusion scintigraphy has been traditionally 
used to assess potential candidates for LVR surgery with 
severe emphysema. Despite this method can assess the 
perfusion pattern in patients with severe emphysematous 
changes, it suffers from low spatial resolution. MRI seems 
to be a more promising technique, since it has shown 
to have high diagnostic accuracy in the detection of 
perfusion abnormalities and the ability to provide lobar 
and segmental assessment of perfusion defects (42,43). 
Yet, none of the afore mentioned methods is able to 
evaluate morphological changes of the lung parenchyma, 
such as thin-collimated high-resolution CT can. Hence, 
full assessment of lung destruction and impaired lung 
function require a combination of morphological and 
functional information or creation of fusion images using 
an additional technique. This is in contrast to dual-energy 
CT:
The technique can be used as a one-stop-shop tool, 
which is able to combine the functional information of 
scintigraphy/MRI with the superior structural information 
of CT. 
Xenon enhanced dual energy CT
A novel technique for the quantification of emphysematous 
lung changes poses Xenon enhanced dual energy CT (XE-
DECT). Xenon is a stable, nobel gas, occurring naturally 
in the atmosphere at a concentration of 0.05%. Its atomic 
Annals of Translational Medicine, Vol 8, No 21 November 2020 Page 7 of 15
© Annals of Translational Medicine. All rights reserved.   Ann Transl Med 2020;8(21):1467 | http://dx.doi.org/10.21037/atm.2020.04.44
Figure 4 Showing the distribution of emphysema in a 64-year-old male patient with COPD on (A,B) computed tomography images in axial 





number is similar to that of iodine (44).
Different trials could show that lung areas enhanced 
by xenon strongly correlate with obstructive ventilation 
impairment (45). Further, ventilation defects depicted on 
Xe-DECT correlate significantly with airflow obstruction 
on lung function tests (46-48). This image information 
is utilized for the depiction emphysema distribution and 
localization and can give important hints which patients 
might be suitable for treatment. There is evidence, that 
a changes of lung parenchyma among inspiration and 
expiration CTs and xenon dynamic change correlate 
significantly, and might be more robust than lung function 
parameters except FEV1 (46). Additionally, XE-DECT 
showed in an animal model that the technique allows the 
quantification of collateral ventilation and detection of 
differences between canine and swine models of bronchial 
obstruction (49). In a study evaluating 1830 CT cerebral 
blood flow examinations using XE-DECT with 32% 
inhaled stable oxygen was used the following adverse events 
were reported: 3.6% occurrence of respiratory rate delay 
greater than 10 seconds, 0.4% cephalgia, 0.2% seizures, 
0.2% nausea and vomiting, and 0.1% change in neurologic 
status (44).
Another important drawback of XE-DECT is that 
Xenon is not readily available in all scanning sites; and 
images have to be acquired in specified centres.
MRI (morphologic, functional and dynamic) 
Morphologic MRI
MRI of the lung is the newest imaging technique, which 
has been established for the evaluation of lung parenchyma, 
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and especially emphysema. This is due to the comparable 
low spatial resolution of MRI and that the technique 
struggles in the lung with the lack of hydrogen ions, which 
are essential for image generation in MRI. While so called 
“plus pathologies” (such as consolidation, atelectasis, mucus 
plugging) can be depicted easier on MRI, the “minus 
pathologies” (such as bullae and emphysema) are more 
difficult to capture. Yet, due to the development of novel 
sequences, the role of MR in lung imaging is changing 
and the technique has achieved a more important role in 
the evaluation of lung parenchyma. Ultrashort and Zero 
Echo-time sequences are nowadays able to capture lung 
parenchyma pathologies almost with the same sensitivity 
as CT does (50-52). Additionally, contrast-enhanced MRI, 
similar to DECT is a noninvasive technique and can be used 
to repeatedly assess clinicopathological severity. The use of 
contrast enhanced MRI allows for obtaining information on 
pulmonary vasculature, and the quantification of the relative 
pulmonary blood (53).
Functional MRI using oxygen or noble gases 
Despite CT might still be superior in the visualization 
of subtle lung parenchyma changes, the power of MRI is 
functional imaging (54,55). Not only lung morphology 
but also lung function can be assessed using pure oxygen 
or noble gases: Hyperpolarized noble gases or molecular 
oxygen function as inhaled MRI contrast agents which are 
able to show regional ventilation and perfusion without 
delivering radiation to the examined patient (56-58).
The depiction of oxygen distribution is of high 
physiological and pathophysiological interest, since 
oxygen transport represents the primary function of 
the lungs and not the distribution of non-physiological 
substances which are assessed in a nuclear medicine-
pulmonary function test (59). The difference in lung 
parenchymal signal intensities between inhaled room air 
and 100% oxygen is minimal, and visual representation 
is generally done by the generation of subtraction maps 
(Figure 5). 
Ohno et al. (60) were one of the first to show the 
feasibility of dynamic oxygen-enhanced MRI in a 
clinical setting. They hypothesized that dynamic oxygen 
enhancement reflects the regional diffusing capacity of the 
lung.
Likewise, with the administration of intravenous contrast 
agents the signal of the lung during dynamic MRI can be 
post-processed by calculating the inflow over time to receive 
quantitative parameters for pulmonary blood flow, blood 
volume and mean transit time (42,61). The quantitative 
maps of lung perfusion obtained by this technique are 
similar to those of perfusion scintigraphy (62,63). Dynamic 
contrast-enhanced MRI has also been recommended for the 
evaluation and follow-up of COPD disease severity (64). 
A different approach is Fourier decomposition lung 
MRI, a novel method for functional lung imaging without 
the use of contrast agents. With the method regional 
lung perfusion and ventilation-related information can be 
assessed simultaneously (65). The strength of the method 
is its short acquisition time of only 30 seconds, but the 
techniques suffers from a lack in robustness, resulting in too 
many artifacts (66). 
Even though CT is potentially better in the depiction 
of subtle lung parenchyma changes, functional parameters 
evaluated with MRI allow for the depiction of ventilation 
and time resolved lung perfusion as well as breathing 
dynamic and functional imaging of the diaphragm. 
Dynamic MRI
Beside the visualisation of morphologic changes as well 
as ventilation and time resolved lung perfusion, MRI is 
Figure 5 Subtraction maps of oxygen enhanced MRI in a patient with chronic obstructive pulmonary disease showing areas of emphysema in the 
upper lobes and middle lobe with lower mean ΔO2 pressure uptake of oxygen compared to the less emphysematous lung parts in the lower lobes.
Max Delta Po2 (mmHg)
B C DA
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Figure 6 Images of 67-year-old male patients before (A) and after (B) undergoing lung volume reduction surgery. (A) resembles typical 
findings of emphysema such as flattening of the hemidiaphragmatic dome; postoperative image (B) shows a different configuration of the 
hemidiaphragmatic dome with a convex shape and lower lung volumes.
BA
a well-recognized technique for the evaluation of lung 
volumes and respiratory mechanics: Apart from upper-
lobe predominance of lung emphysema and heterogeneity, 
MRI is able to capture impaired motion of the respiratory 
muscles inclusive the diaphragm, which are additional 
factors in chronic obstructive pulmonary disease. This is 
possible, because MRI is an imaging technique, which does 
not expose the patient to radiation, and image acquisitions 
can therefore be performed over a longer time. This 
gives the possibility to evaluate not only static images, but 
to investigate also for the dynamic and the function of 
respiration and respiratory muscles. Suga et al. (67) could 
demonstrate that with dynamic MRI it is possible to non-
invasively visualize dynamic respiratory motions of the 
respiratory muscles. Martini et al. could further show, that 
the evaluation of breathing dynamic might be beneficial 
in treatment planning and selection of patients who might 
benefit the most from LVR (Figure 6) (68). 
Radiomics in emphysema
Interpretation of medical images relies on visual assessment 
by an observer, mostly the radiologist. Gained knowledge 
of anatomical and physiological variations determines 
the recognition of patterns that are within normal ranges 
and allows identifying appearances outside these ranges 
to be categorized as pathologic (69). More and more, 
advancement in standardisation efforts, applications of 
analysis techniques to extract quantitative information. 
Radiomics, defined as the conversion of medical images 
to higher-dimensional data, is a novel research area: The 
technique has attracted increased attention in recent years 
and several studies could show that radiomics can be 
beneficial for prognosis and diagnosis of multiple diseases, 
especially malignancies (32-34). Feature extraction is a 
crucial step in radiomics and implies the computation of 
texture, density and shape features from predefined regions 
of interest (ROIs). The biggest advantage of radiomics is 
that with the technique it is possible to obtain an objective 
quantification of tissue characteristics and abnormalities 
in radiological images (16-19). Due to the high objectivity 
and reproducibility of data, radiomics shows great potential 
as support for clinical decision-making (20), since it is not 
hampered by subjective evaluation or experience of the 
radiologist.
To date, an amount of neural networks and statistical 
models are available to help radiologists and clinicians with 
objective and reproducible computer-based evaluation of 
lung parenchyma. For instance, CALIPER (Computer 
Aided Lung Informatics for Pathology Evaluation and 
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Figure 7 A 43-year-old female patient with upper lobe predominant centrilobular emphysema (A) reconstructed with filtered back 
projection (FBP) and (B) reconstructed with advanced modeled iterative reconstruction (ADMIRE) strength level 5.
BA
Rating) developed at Mayo Clinic (Rochester, MN), is 
a digital platform for a near real-time qualitative and 
quantitative assessment of lung parenchyma patterns on CT 
(70,71).
Further, Occhipinti et al. could show that presence and 
severity of emphysematous lung changes in subjects with 
chronic obstructive pulmonary disease, as quantified by CT 
metrics and radiomics can be estimated by mathematical 
modeling of airway function obtained from standard lung 
function testing (72).
Quantitative imaging biomarkers have the potential 
to provide objective decision-support tools for patient 
the management (69). However, despite the promising 
results, radiomics is not yet implemented in the daily 
clinical routine, mostly due to its vulnerability in changes 
of scanning protocols: differences in scanning parameters 
such as type of CT scanner, tube voltage, tube current, 
reconstruction kernel and contrast agent may affect image 
texture and may hamper the functionality of an algorithm 
previously optimized for other scanning parameters. 
Before Radiomics and Artificial Intelligence can be applied, 
measurement variability needs to be understood and systems 
for data acquisition and analysis harmonised (69).
Iterative reconstruction: how to overcome the 
changes in image texture
In spite of the considerable advantages of quantitation, 
only a few quantitative imaging scores are used in clinical 
decision-making due to several obstacles: (I) Difficulties 
in the harmonization of data acquisition and analysis, (II) 
lack of international standards without routine quality 
assurance (QA) and quality control (QC) processes, 
(III) poor validation of quantitative biomarkers that are 
subject to errors in interpretation (69). For example, 
several trials indicate that automated quantification of 
emphysematous lung changes is highly reproducible, when 
identical scan parameters and reconstruction algorithms 
are used (5). Yet, different scanners and especially different 
reconstruction algorithms might hamper the reliable 
function of semiquantitative and quantitative approaches 
due to the different image appearance (Figure 7): different 
authors have already criticized iterative reconstruction (IR) 
techniques in visual approaches for the artificial texture of 
the reconstructed images and the appearance changes of 
images reconstructed with IR (73,74). Martini et al. (75), 
for example, found that the use of IR techniques was 
not beneficial for increasing sensitivity for the detection 
interstitial lung changes in reduced dose protocols, despite 
image noise was reduced. 
Messerli et al. (76), who evaluated the impact of IR and 
reduced dose CT on quantitative emphysema evaluation, 
found that the mean lung attenuation of reduced dose CT 
was significantly altered by IR. In addition, the agreement 
of mean lung attenuation between standard dose and 
reduced dose CT with IR was poor; and the agreement 
between standard and reduced dose CT without the use of 
IR was substantial. These findings imply that for CT with 
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reduced dose protocols or IR an adaptation of the generally 
accepted and recommended thresholds for HU values 
(24,25) is necessary in order to distinguish emphysematous 
lung parenchyma from normal lung tissue. Since the 
agreement between standard and reduced dose CT without 
the use of IR was substantial, a different approach could be 
applied: for mere quantification, images not post-processed 
with IR algorithms could be used, while using the post 
processed only for the visual assessment.
Risk assessment in patients with emphysema
Different studies could show, that lung emphysema detected 
on CT is associated with important clinical outcomes, such 
as mortality (77-80). Quantitative assessed emphysematous 
lung changes are also associated with increased all-cause 
mortality in subjects with chronic obstructive pulmonary 
disease (20). Lynch et al. Found that the visual presence 
and severity of emphysema is associated with significantly 
increased mortality risk, independent of the quantitative 
severity of emphysema (20). Smith et al. reported in a 
systematic literature review that lung emphysema visually 
detected on CT is linked with increased incidence of lung 
cancer. Interestingly, this association did not hold true for 
automated emphysema detection (78): The two largest 
prospective studies derived from screening trials after 
adjustment for smoking history and airflow obstruction, 
reported a significant risk of lung cancer in patients were 
emphysema was visually detected on chest CT (81,82). In 
contrast to this, two case–control studies were the presence 
of lung emphysema was assessed with quantitative approach, 
no association of emphysema with lung cancer could be 
found (83,84). The reason for these results might be that 
quantitative or semiquantitative approaches are more 
sensitive in the detection of also subtle emphysema, which 
overall has lower impact on malignancy development.
A dif ferent approach was to evaluate dif ferent 
emphysema distributions and their clinical relevance (9): 
in this study centrilobular and panlobular emphysematous 
lung changes were linked with more severe symptoms, 
and reduced exercise capacity independent of airflow 
obstruction. Contrary to this, paraseptal emphysema was 
only of little physiologic significance. Lung emphysema 
was also seen in a substantial minority of subjects without 
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